Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trialZefei Jiang, Yuan Sheng, Jiuwei Cui et al.|Nature Medicine|2024Cited by 121
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancerYuan Sheng, Quchang Ouyang, Tao Sun et al.|Future Oncology|2024Cited by 1
Abstract P5-09-29: Trastuzumab Combined with Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-Pathological Complete Response HER2-Positive Early Breast Cancer Following Neoadjuvant Therapy: A Multicenter Phase II StudyChuan Wang, Zhe Zhang, Fangmeng Fu et al.|Clinical Cancer Research|2025Cited by 0